ASH 2021 packed with practice-changing hematologic cancer data

December 10, 2021

In an article in OncLive experts specializing in multiple myeloma mention what they believe to be the top studies presented at the 2021 ASH annual meeting and how their findings have the potential to change clinical practice.

Share this post

More to explore

iStopMM study changes the definition of multiple myeloma precursor condition

February 5, 2023

Recently an interview appeared in Nordic Life Science with Thorir Long author of Defining new reference intervals for serum free light chains in individuals with

iStopMM team member receives IMS Young Investigator Award

August 27, 2022

We are proud to announce that a PhD student at the University of Iceland and a member of the iStopMM team Jón Þórir Óskarsson was

Vilhjalmur Steingrimsson PhD

September 30, 2021

Vilhjálmur Steingrimsson defended his doctoral thesis Survival and complications in patients with chronic lymphocytic leukemia in the pre-ibrutinib era on the 24th September. Opponents were